Dr. Amy Miner Ross | Immunology | Best Innovation Award

OHSU, United States.

Dr. Amy Miner Ross, Ph.D., R.N., C.N.S., is an esteemed nursing scholar and educator at Oregon Health & Science University (OHSU) School of Nursing. With a rich background in neuroscience nursing, critical care, and health systems leadership, she has significantly contributed to research on inflammatory response in stroke/TIA and work environments in nursing. Over the years, Dr. Ross has received multiple prestigious awards, served in key academic leadership roles, and has been an advocate for evidence-based nursing practice and education.

Profile

Scopus

Google Scholar

📚 Education

Dr. Amy Miner Ross holds a Ph.D. in Nursing from Oregon Health & Science University (2006), where her research focused on the inflammatory response in stroke and transient ischemic attacks (TIA). She earned an M.S. in Nursing from the University of California, San Francisco (1987), specializing in Physiological Nursing and Physiology. Her academic foundation includes a B.S. in Nursing from the University of San Francisco (1978) and an A.S. in Science from City College of San Francisco (1974). With a strong background in nursing education and research, Dr. Ross has made significant contributions to the understanding of physiological responses in critical health conditions.

👩‍🏫 Professional Experience

Dr. Amy Miner Ross is an Associate Professor at the Oregon Health & Science University (OHSU) School of Nursing, where she has been a faculty member since 2006. She has held various leadership roles, including Interim Director of the Doctor of Philosophy Program (2020–2022) and Director of Health Systems & Organizational Leadership (2014–2024). From 2006 to 2012, she was also a faculty member in the Doctor of Nursing Practice Program.

Beyond academia, Dr. Ross has extensive clinical and research experience. She served as a Research Consultant & Director of Professional Development at Asante Health System (2005–2008) and worked as a Neuroscience Clinical Nurse Specialist at Rogue Valley Medical Center (2003–2006). Earlier in her career, she was a Clinical Nurse Specialist in Neurosurgery Research at the University of California, San Francisco (1983–1989), contributing to advancements in neurosurgical care and research.

🔬 Research Interests

Dr. Ross's research focuses on:

Inflammatory response in stroke/TIA

Peripheral immune response trajectories in stroke patients

Work environments & nursing care quality

Health systems leadership & nursing education

She has been involved in NIH-funded research and has received grants for projects investigating stroke immunology, healthcare environments, and virtual reality applications in nursing.

🏆 Awards & Honors

OHSU SON Excellence in Teaching Award (2023)

OHSU Graduate Faculty Recognition Award (2023, 2016)

FLAME Award – Faculty Mentor Nominee (2023)

Sakai Inclusivity Award – OHSU Teaching Learning Center (2022)

Top Downloaded Paper Award – Journal of Nursing Scholarship (2018-2019)

Neuroscience Nursing Foundation New Investigator Award (2013)

Pan American Games Gold Medalist – Synchronized Swimming (1971)

📄 Selected Publications

Liu, J., You, L., Zheng, J., Ross, A.M., & Liu, K. (2016). Effects of work environments on the quality of care in ICUs: a multisite study in China. Journal of Nursing Care Quality. PMID: 26796973 [Cited 25 times]

Ross, A. M., Lee, C. S., & Lutsep, H. (2015). Influence of Gender and Age on the Peripheral Immune Response in Stroke. Journal of Cardiovascular Nursing. PMID: 25774839 [Cited 6 times]

Ross, A. M. & Lee, C. S. (2015). Description and identification of the peripheral immune response trajectories over time in first-time & recurrent stroke/TIA. Journal of Neuroscience Nursing, 47(5), 256-262. PMID: 26236950 [Cited 3 times]

Li, K., Yan, T., You, L., Li, R., & Ross, A. M. (2015). International classification of functioning, disability and health categories for spinal cord injury nursing in China. Disability and Rehabilitation, 37(1), 25-32. PMID: 24564326 [Cited 15 times]

Prof. Abdolkarim Sheikhi | Vaccine | Best Innovation Award

Queens University, Canada.

Abdolkarim Sheikhi is an Iranian immunologist and professor at Dezful University of Medical Sciences. With a distinguished career spanning over three decades, he has made significant contributions to the field of immunology, particularly in NK cell activity, immune responses, and molecular immunology. He has held key academic positions, supervised numerous research projects, and has been actively involved in establishing laboratories and clinical centers. His expertise extends to advanced immunological techniques, teaching, and scientific society memberships.

🎓 Education

Abdolkarim Sheikhi earned his B.Sc. in Biological Sciences from Shahid Chamran University, Iran (1985–1989), followed by an M.Sc. in Medical Immunology from Tarbiat Modarres University, Iran (1989–1992), where he researched Natural Killer (NK) activity assays in cancerous patients and normal individuals. He then completed his Ph.D. in Medical Immunology at Shiraz University of Medical Sciences, Iran (1996–2002), focusing on the influence of soluble HLA molecules on NK cells, particularly their quantity and role in malignant peritoneal and pleural effusions, shedding light on immune interactions in cancer progression.

💼 Experience

Professor Abdolkarim Sheikhi has had a distinguished academic career in Immunology, currently serving as a Professor at the Department of Immunology, Dezful University of Medical Sciences (2016–Present). Before this, he was an Associate Professor at the same institution (2010–2016) and at Zanjan University of Medical Sciences (2009–2010). His journey in academia began as an Assistant Professor (2002–2009) and an Academic Staff Member (1992–2002) at Zanjan University of Medical Sciences. In addition to his teaching and research, he has held Visiting Scientist positions at Queen’s University (Canada), Universitätsklinikum Kiel (Germany), and VUmc University (Netherlands), contributing to global immunology research.

🔬 Research Interests

Immunology: Natural Killer (NK) cells, immune regulation, immune responses in infections and cancers

Molecular Immunology: sHLA molecules, T cell activation, antigen presentation

Autoimmune Diseases & Allergies

Cancer Immunotherapy & Monoclonal Antibodies

📚 Selected Publications

Sheikhi, A., Baghaie, L., Rahbarizadeh, F., Safarzadeh Kozani, P., Moradian, C., Davidi, M., Baharifar, N., Kaboli, G., Sheikhi, M., Li, Y., et al. (2025).
Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines, and Activates Natural Killer Cell Cytotoxicity.
Vaccines.

Yazdanpanah‐Samani, M., Ramezani, A., Sheikhi, A., Mostafavi‐Pour, Z., Erfani, N. (2024).
Anti‐PD‐L1 Chimeric Antigen Receptor Natural Killer Cell: Characterization and Functional Analysis.
APMIS.

Akbarian, S., Sheikhi, M., Khedri, P., Baharifar, N., Khalaf Shamsabadi, F., Davidi, M. R., Khazaei, H. A., Assarian, H., Sheikhi, A. (2023).
The Correlation Between Humoral Immune Responses and Severity of Clinical Symptoms in COVID-19 Patients.
Epidemiology and Infection.

Momtazan, S., Ramezani, S., Momeni, A., Sheikhi, A. (2023).
The Potential Benefits of Ginger in Cancer Therapy.
Trends in Medical Sciences.